Cargando…

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target

Immune checkpoint therapy has achieved significant efficacy by blocking inhibitory pathways to release the function of T lymphocytes. In the clinic, anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) monoclonal antibodies (mAbs) have progressed to first-line monotherapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Wenjing, Zhao, Mingfang, Wang, Ruoyu, Li, Heming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444356/ https://www.ncbi.nlm.nih.gov/pubmed/34526102 http://dx.doi.org/10.1186/s13045-021-01161-8

Ejemplares similares

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
por: Feng, Yanyan, et al.
Publicado: (2020)

Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects
por: Sulimai, Nurul H., et al.
Publicado: (2022)

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis
por: Denicolò, Sara, et al.
Publicado: (2022)

Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8(+)regulatory T cells-mediated long-term graft survival
por: Bézie, Séverine, et al.
Publicado: (2011)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Variations in Fibrinogen-like 1 (FGL1) Gene Locus as a Genetic Marker Related to Fat Deposition Based on Pig Model and Liver RNA-Seq Data
por: Piórkowska, Katarzyna, et al.
Publicado: (2022)

Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma
por: Lin, Mingen, et al.
Publicado: (2023)

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer
por: Li, Jia-Jun, et al.
Publicado: (2023)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

The role of Fibrinogen-like proteins in Cancer
por: Yu, Jing, et al.
Publicado: (2021)

Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4(+) CD25(+) Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice
por: Wang, Junhua, et al.
Publicado: (2015)

Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection
por: Tsai, Hsiang‐i, et al.
Publicado: (2021)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Crystal Structure of the Tetrameric Fibrinogen-like Recognition Domain of Fibrinogen C Domain Containing 1 (FIBCD1) Protein
por: Shrive, Annette K., et al.
Publicado: (2014)

Next generation of immune checkpoint inhibitors and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021)

SHP-1: the next checkpoint target for cancer immunotherapy?
por: Watson, H. Angharad, et al.
Publicado: (2016)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Abnormal Expression of the LAG-3/FGL-1 Signaling Pathway in Patients with Early-Onset Preeclampsia
por: Liang, Yue, et al.
Publicado: (2022)

Fibrinogen-Like Protein 1 as a Novel Biomarker of Psoriasis Severity
por: Sun, Xiaoying, et al.
Publicado: (2022)

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
por: Chai, Dafei, et al.
Publicado: (2021)

Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma
por: Yang, Changjie, et al.
Publicado: (2023)

Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization
por: Demchev, Valeriy, et al.
Publicado: (2013)

The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating MYC-target genes
por: Tang, Xi-Yang, et al.
Publicado: (2022)

FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
por: Sun, Cuilan, et al.
Publicado: (2020)

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Dynamics of Functionally Graded Laminated (FGL) Media—Theoretical Tolerance Modelling
por: Jędrysiak, Jarosław
Publicado: (2023)

The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
por: Hua, Nanni, et al.
Publicado: (2022)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2
por: Fu, Yong, et al.
Publicado: (2020)

tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1
por: Wang, Yang, et al.
Publicado: (2022)

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
por: An, Tianhui, et al.
Publicado: (2023)

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023)

Next generation of immune checkpoint therapy in cancer: new developments and challenges
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

Proteomics identifies a novel role of fibrinogen-like protein 1 in Crohn’s disease
por: Sun, Xue-Liang, et al.
Publicado: (2021)

Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1
por: Zhang, Wan-ting, et al.
Publicado: (2021)

Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells
por: Son, Yeonghoon, et al.
Publicado: (2021)

Identification and characterization of the fibrinogen-like domain of fibrinogen-related proteins in the mosquito, Anopheles gambiae, and the fruitfly, Drosophila melanogaster, genomes
por: Wang, Xinguo, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_m4pjtcrdb188q2h2qne532627c